BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 3356624)

  • 1. Efficacy of albendazole against Strongyloides ratti and S. stercoralis in vitro, in mice, and in normal and immunosuppressed dogs.
    Grove DI; Lumsden J; Northern C
    J Antimicrob Chemother; 1988 Jan; 21(1):75-84. PubMed ID: 3356624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strongyloides ratti and S. stercoralis: the effects of thiabendazole, mebendazole, and cambendazole in infected mice.
    Grove DI
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):469-76. PubMed ID: 7081540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of 22, 23-dihydroavermectin B1 on Strongyloides ratti and S. stercoralis infections in mice.
    Grove DI
    Ann Trop Med Parasitol; 1983 Aug; 77(4):405-10. PubMed ID: 6688943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albendazole and thiabendazole in murine strongyloidiasis.
    Mojon M; Saura C; Roojee N; Tran Manh Sung R
    J Antimicrob Chemother; 1987 Jan; 19(1):79-85. PubMed ID: 3558170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of thiabendazole, mebendazole and cambendazole in normal and immunosuppressed dogs infected with a human strain of Strongyloides stercoralis.
    Grove DI; Northern C
    Trans R Soc Trop Med Hyg; 1988; 82(1):146-9. PubMed ID: 3176142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strongyloides stercoralis: hyperinfection in immunosuppressed dogs.
    Schad GA; Hellman ME; Muncey DW
    Exp Parasitol; 1984 Jun; 57(3):287-96. PubMed ID: 6723900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempts to establish infections with Strongyloides stercoralis in mice and other laboratory animals.
    Dawkins HJ; Grove DI
    J Helminthol; 1982 Mar; 56(1):23-6. PubMed ID: 6978359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strongyloides ratti: the role of interleukin-5 in protection against tissue migrating larvae and intestinal adult worms.
    Watanabe K; Sasaki O; Hamano S; Kishihara K; Nomoto K; Tada I; Aoki Y
    J Helminthol; 2003 Dec; 77(4):355-61. PubMed ID: 14627453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strongyloides stercoralis eggs in the stools during anticancer therapy.
    Jayshree RS; Sridhar H; Babu G; Suresh TM
    Indian J Gastroenterol; 2001; 20(4):160-1. PubMed ID: 11497180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Strongyloides stercoralis infection.
    Hong SJ; Han JH
    Korean J Parasitol; 1999 Jun; 37(2):117-20. PubMed ID: 10388270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
    Nontasut P; Muennoo C; Sa-nguankiat S; Fongsri S; Vichit A
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of the protective immune response in the mouse to Strongyloides ratti.
    Grove DI; Northern C
    J Helminthol; 1989 Dec; 63(4):307-14. PubMed ID: 2600413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species.
    Kotze AC; Clifford S; O'Grady J; Behnke JM; McCarthy JS
    Am J Trop Med Hyg; 2004 Nov; 71(5):608-16. PubMed ID: 15569793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course of infection in rats given small primary doses of Strongyloides ratti and S. venezuelensis.
    Carter KC; Wilson PA
    J Helminthol; 1989 Jun; 63(2):107-14. PubMed ID: 2738379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strongyloides ratti: in vitro and in vivo activity of tribendimidine.
    Keiser J; Thiemann K; Endriss Y; Utzinger J
    PLoS Negl Trop Dis; 2008 Jan; 2(1):e136. PubMed ID: 18235851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.
    Suputtamongkol Y; Premasathian N; Bhumimuang K; Waywa D; Nilganuwong S; Karuphong E; Anekthananon T; Wanachiwanawin D; Silpasakorn S
    PLoS Negl Trop Dis; 2011 May; 5(5):e1044. PubMed ID: 21572981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis.
    Satoh M; Toma H; Kiyuna S; Shiroma Y; Kokaze A; Sato Y
    Am J Trop Med Hyg; 2004 Jul; 71(1):107-11. PubMed ID: 15238698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis.
    Keiser J; Häberli C
    Parasit Vectors; 2021 Dec; 14(1):615. PubMed ID: 34949209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strongyloides stercoralis in a patient complaining of chronic diarrhea].
    Culha G; Savaş L; Onlen Y
    Turkiye Parazitol Derg; 2006; 30(4):293-5. PubMed ID: 17309031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albendazole in the treatment of strongyloidiasis.
    Pungpak S; Bunnag D; Chindanond D; Radmoyos B
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):207-10. PubMed ID: 3672182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.